forum health semaglutide Oral Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Peptide Therapy for Weight Loss

Learn how to build a sustainable GLP-1 weight management strategy that supports every stagefrom behavior change to maintenancefor long-term results.

We ran a synthetic panel on GLP-1s impact on food and beverage categories

The studies involved subjects, rather small numbers in each case, who had diabetes, non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), coronary disease or had kidney transplants

Pemvidutide : A GLP-1/glucagon dual agonist from Altimmune

An analysis of social media posts and a remote study of individuals with obesity who reported using semaglutide and tirzepatide, has found that the drugs decreased cravings and reduced alcohol consumption, according to Virginia Tech researchers."These findings add to a growing literature that these medications may curb dangerous drinking habits," said Warren Bickel, Virginia Tech Carilion Behavioral Health Research Professor at the Fralin Biomedical Research Institute at VTC and corresponding au